SS18 and malignant mesothelioma: Although no SS18-SSX fusion led us clearly exclude synovial sarcoma in the present case, the histologic distinction of synovial sarcoma from malignant mesothelioma may be difficult because of the combination of epithelioid and spindle cells, potentially sharing locations, and immunopositivity for calretinin in both tumors [9].